Dietary curcumin supplementation counteracts reduction in levels of molecules involved in energy homeostasis after brain trauma.
Traumatic brain injury (TBI) is followed by an energy crisis that compromises the capacity of the brain to cope with challenges, and often reduces cognitive ability. New research indicates that events that regulate energy homeostasis crucially impact synaptic function and this can compromise the capacity of the brain to respond to challenges during the acute and chronic phases of TBI. The goal of the present study is to determine the influence of the phenolic yellow curry pigment curcumin on molecular systems involved with the monitoring, balance, and transduction of cellular energy, in the hippocampus of animals exposed to mild fluid percussion injury (FPI). Young adult rats were exposed to a regular diet (RD) without or with 500 ppm curcumin (Cur) for four weeks, before an FPI was performed. The rats were assigned to four groups: RD/Sham, Cur/Sham, RD/FPI, and Cur/FPI. We found that FPI decreased the levels of AMP-activated protein kinase (AMPK), ubiquitous mitochondrial creatine kinase (uMtCK) and cytochrome c oxidase II (COX-II) in RD/FPI rats as compared to the RD/sham rats. The curcumin diet counteracted the effects of FPI and elevated the levels of AMPK, uMtCK, COX-II in Cur/FPI rats as compared to RD/sham rats. In addition, in the Cur/sham rats, AMPK and uMtCK increased compared to the RD/sham. Results show the potential of curcumin to regulate molecules involved in energy homeostasis following TBI. These studies may foster a new line of therapeutic treatments for TBI patients by endogenous upregulation of molecules important for functional recovery.
Sharma
S
S
Department of Physiological Science, UCLA, 621 Charles E. Young Drive, Los Angeles, CA 90095, USA.
Zhuang
Y
Y
Ying
Z
Z
Wu
A
A
Gomez-Pinilla
F
F
D000091162:AMP-Activated Protein Kinase Kinases; D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage*; D015153:Blotting, Western; D001930:Brain Injuries / Q000178:diet therapy* / Q000378:metabolism; D052281:Creatine Kinase, Mitochondrial Form / Q000378:metabolism; D003474:Curcumin / Q000008:administration & dosage*; D004032:Diet; D003576:Electron Transport Complex IV / Q000378:metabolism; D006624:Hippocampus / Q000187:drug effects* / Q000378:metabolism; D006706:Homeostasis / Q000187:drug effects* / Q000502:physiology; D007150:Immunohistochemistry; D008297:Male; D010766:Phosphorylation; D011494:Protein Kinases / Q000378:metabolism; D011897:Random Allocation; D051381:Rats; D017207:Rats, Sprague-Dawley; D056564:Sirtuin 1; D037761:Sirtuins / Q000378:metabolism
D000894:Anti-Inflammatory Agents, Non-Steroidal; C117108:cytochrome C oxidase subunit II; D003576:Electron Transport Complex IV; D011494:Protein Kinases; D000091162:AMP-Activated Protein Kinase Kinases; D052281:Creatine Kinase, Mitochondrial Form; C488368:Sirt1 protein, rat; D056564:Sirtuin 1; D037761:Sirtuins; D003474:Curcumin